Urifen 7.5mg Tablet
By Urifen
Rx
10 Tablet in a Strip

Composition
Darifenacin(7.5mg)

Manufacturer - Ajanta Pharma Ltd
Ajanta House, Charkop, Kandivli West, Mumbai 400 067, India

Expires on or after
October, 2025

liver
When using Urifen 7.5mg Tablet, it is important to be cautious if you have severe liver disease. Patients with severe liver issues may require adjustments to their dosage of Urifen 7.5mg Tablet. It is advisable to consult your doctor before taking this medication to ensure your liver condition is properly considered.

kidney
Urifen 7.5mg Tablet is safe for patients with kidney disease, and no dose adjustment is needed. Inform your doctor about any existing kidney issues.

alcohol
Consult your doctor when consuming alcohol with Urifen 7.5mg Tablet.

driving
Urifen 7.5mg Tablet may lead to dizziness, blurred vision, trouble sleeping, or drowsiness, affecting driving ability.

pregnancy
Urifen 7.5mg Tablet may not be safe to use during pregnancy. Animal studies indicate potential harm to the developing baby. Consult your doctor as benefits and risks need to be considered before taking this medication.

breastfeeding
Urifen 7.5mg Tablet may not be safe during breastfeeding. Limited data suggests it could pass into breastmilk and harm the baby.
Habit Forming | No |
Chemical Class | Diphenylmethane Derivative |
Therapeutic Class | UROLOGY |
Action Class | Selective M3 anticholinergic (Bladder) |
₹235
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 01-Oct-2024